Cargando…

COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021

The SARS-CoV-2 Delta variant, first identified in October 2020, quickly became the dominant variant worldwide. We used publicly available data to explore the relationship between illness and death (peak case rates, death rates, case-fatality rates) and selected predictors (percentage vaccinated, per...

Descripción completa

Detalles Bibliográficos
Autores principales: Atherstone, Christine J., Guagliardo, Sarah Anne J., Hawksworth, Anthony, O’Laughlin, Kevin, Wong, Kimberly, Sloan, Michelle L., Henao, Olga, Rao, Carol Y., McElroy, Peter D., Bennett, Sarah D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461680/
https://www.ncbi.nlm.nih.gov/pubmed/37494699
http://dx.doi.org/10.3201/eid2909.230142
_version_ 1785097889226162176
author Atherstone, Christine J.
Guagliardo, Sarah Anne J.
Hawksworth, Anthony
O’Laughlin, Kevin
Wong, Kimberly
Sloan, Michelle L.
Henao, Olga
Rao, Carol Y.
McElroy, Peter D.
Bennett, Sarah D.
author_facet Atherstone, Christine J.
Guagliardo, Sarah Anne J.
Hawksworth, Anthony
O’Laughlin, Kevin
Wong, Kimberly
Sloan, Michelle L.
Henao, Olga
Rao, Carol Y.
McElroy, Peter D.
Bennett, Sarah D.
author_sort Atherstone, Christine J.
collection PubMed
description The SARS-CoV-2 Delta variant, first identified in October 2020, quickly became the dominant variant worldwide. We used publicly available data to explore the relationship between illness and death (peak case rates, death rates, case-fatality rates) and selected predictors (percentage vaccinated, percentage of the population >65 years, population density, testing volume, index of mitigation policies) in 45 high-income countries during the Delta wave using rank-order correlation and ordinal regression. During the Delta-dominant period, most countries reported higher peak case rates (57%) and lower peak case-fatality rates (98%). Higher vaccination coverage was protective against peak case rates (odds ratio 0.95, 95% CI 0.91–0.99) and against peak death rates (odds ratio 0.96, 95% CI 0.91–0.99). Vaccination coverage was vital to preventing infection and death from COVID-19 during the Delta wave. As new variants emerge, public health authorities should encourage the uptake of COVID-19 vaccination and boosters.
format Online
Article
Text
id pubmed-10461680
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-104616802023-09-01 COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021 Atherstone, Christine J. Guagliardo, Sarah Anne J. Hawksworth, Anthony O’Laughlin, Kevin Wong, Kimberly Sloan, Michelle L. Henao, Olga Rao, Carol Y. McElroy, Peter D. Bennett, Sarah D. Emerg Infect Dis Research The SARS-CoV-2 Delta variant, first identified in October 2020, quickly became the dominant variant worldwide. We used publicly available data to explore the relationship between illness and death (peak case rates, death rates, case-fatality rates) and selected predictors (percentage vaccinated, percentage of the population >65 years, population density, testing volume, index of mitigation policies) in 45 high-income countries during the Delta wave using rank-order correlation and ordinal regression. During the Delta-dominant period, most countries reported higher peak case rates (57%) and lower peak case-fatality rates (98%). Higher vaccination coverage was protective against peak case rates (odds ratio 0.95, 95% CI 0.91–0.99) and against peak death rates (odds ratio 0.96, 95% CI 0.91–0.99). Vaccination coverage was vital to preventing infection and death from COVID-19 during the Delta wave. As new variants emerge, public health authorities should encourage the uptake of COVID-19 vaccination and boosters. Centers for Disease Control and Prevention 2023-09 /pmc/articles/PMC10461680/ /pubmed/37494699 http://dx.doi.org/10.3201/eid2909.230142 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Atherstone, Christine J.
Guagliardo, Sarah Anne J.
Hawksworth, Anthony
O’Laughlin, Kevin
Wong, Kimberly
Sloan, Michelle L.
Henao, Olga
Rao, Carol Y.
McElroy, Peter D.
Bennett, Sarah D.
COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021
title COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021
title_full COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021
title_fullStr COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021
title_full_unstemmed COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021
title_short COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021
title_sort covid-19 epidemiology during delta variant dominance period in 45 high-income countries, 2020–2021
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461680/
https://www.ncbi.nlm.nih.gov/pubmed/37494699
http://dx.doi.org/10.3201/eid2909.230142
work_keys_str_mv AT atherstonechristinej covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021
AT guagliardosarahannej covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021
AT hawksworthanthony covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021
AT olaughlinkevin covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021
AT wongkimberly covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021
AT sloanmichellel covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021
AT henaoolga covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021
AT raocaroly covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021
AT mcelroypeterd covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021
AT bennettsarahd covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021